文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

基于锥形束CT的剂量累积分析:前列腺癌原发放疗中优势前列腺内病灶的递送剂量评估

Cone beam CT-based dose accumulation and analysis of delivered dose to the dominant intraprostatic lesion in primary radiotherapy of prostate cancer.
PubMed 文献 · Radiat Oncol · 2021-10-26

结果显示PTVDIL、PTVBoost和PTV的靶区覆盖优良,无剂量不足;膀胱平均DMean高于计划(19.4±7.4 Gy vs 18.8±7.5 Gy,p<0.001),阴茎球平均DMean低于计划(29.1±14.0 Gy vs 29.8±14.4 Gy,p<0.001);位于后内侧外周带的背侧DIL递送剂量显著低于腹侧病灶,平均DMean差异为2.2 Gy(95%CI 1.3-3.1 Gy,p<0.001)。

要点

  • CBCT剂量累积显示PTVDIL、PTVBoost和PTV靶区覆盖优良,无剂量不足。
  • 背侧DIL递送剂量较腹侧显著降低,平均DMean差异2.2 Gy(95%CI 1.3-3.1 Gy)。
  • 膀胱平均DMean高于计划,阴茎球平均DMean低于计划,差异均具统计学意义。

核心结论

  • 基于CBCT的剂量累积表明DIL及危及器官的递送剂量在计划限值内,但邻近直肠的指标病灶需谨慎评估靶区覆盖以避免剂量不足。

主要发现

  • 共分析338次CBCT,PTVDIL、PTVBoost和PTV的DMean、D95%、D02%和D98%均无剂量不足病例。
  • 直肠递送DMean与计划无显著差异;膀胱平均DMean高于计划(19.4±7.4 Gy vs 18.8±7.5 Gy,p<0.001);阴茎球平均DMean低于计划(29.1±14.0 Gy vs 29.8±14.4 Gy,p<0.001)。
  • 背侧DIL(前列腺后内侧外周带)递送剂量显著低于腹侧病灶,平均DMean差异2.2 Gy(95%CI 1.3-3.1 Gy,p<0.001)。

临床怎么用

  • 利用CBCT剂量累积可验证DIL和危及器官的实际递送剂量,对邻近直肠的病灶应谨慎评估靶区覆盖以避免剂量不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Evaluation of delivered dose to the dominant intraprostatic lesion (DIL) for moderately hypofractionated radiotherapy of prostate cancer by cone beam computed tomography (CBCT)-based dose accumulation and target coverage analysis. METHODS: Twenty-three patients with localized prostate cancer treated with moderately hypofractionated prostate radiotherapy with simultaneous integrated boost (SIB) between December 2016 and February 2020 were retrospectively analyzed. Included patients were required to have an identifiable DIL on bi-parametric planning magnetic resonance imaging (MRI). After import into the RayStation treatment planning system and application of a step-wise density override, the fractional doses were computed on each CBCT and were consecutively mapped onto the planning CT via a deformation vector field derived from deformable image registration. Fractional doses were accumulated for all CBCTs and interpolated for missing CBCTs, resulting in the delivered dose for PTVDIL, PTVBoost, PTV, and the organs at risk. The location of the index lesions was recorded according to the sector map of the Prostate Imaging Reporting and Data System (PIRADS) Version 2.1. Target coverage of the index lesions was evaluated and stratified for location. RESULTS: In total, 338 CBCTs were available for analysis. Dose accumulation target coverage of PTVDIL, PTVBoost, and PTV was excellent and no cases of underdosage in DMean, D95%, D02%, and D98% could be detected. Delivered rectum DMean did not significantly differ from the planned dose. Bladder mean DMean was higher than planned with 19.4 ± 7.4 Gy versus 18.8 ± 7.5 Gy, p < 0.001. The penile bulb showed a decreased delivered mean DMean with 29.1 ± 14.0 Gy versus 29.8 ± 14.4 Gy, p < 0.001. Dorsal DILs, defined as DILs in the posterior medial peripheral zone of the prostate, showed a significantly lower delivered dose with a mean DMean difference of 2.2 Gy (95% CI 1.3-3.1 Gy, p < 0.001) compared to ventral lesions. CONCLUSIONS: CBCT-based dose accumulation showed an adequate delivered dose to the dominant intraprostatic lesion and organs at risk within planning limits. Cautious evaluation of the target coverage for index lesions adjacent to the rectum is warranted to avoid underdosage.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Tamihardja J, Cirsi S, Kessler P, et al. Cone beam CT-based dose accumulation and analysis of delivered dose to the dominant intraprostatic lesion in primary radiotherapy of prostate cancer. Radiat Oncol. 2021. PMID: 34702305. doi:10.1186/s13014-021-01933-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。